The model for development of new pharmaceutical products is changing rapidly and your company’s strategy must respond, whether you are a large pharmaceutical company, or an emerging biotech company. Alternative sourcing programs are emerging. Alliances are becoming more and more central to new product development as alliance-centric external development programs emerge. Movements towards better integration of business development and alliance management functions, and better linkage of alliances and acquisition activity, are also transforming how companies are finding, evaluating, structuring and negotiating deals and working with their external partners. Be part of this Premier Event!

FEATURED PRESENTATIONS:

The Evolution of a BioPharma Partnership - From Technology Platform to Drug Discovery & Development
Jörn Aldag, President and Chief Executive Officer, Evotec
Gad Bitton, Global Alliance Director, Roche Pharma Partnering

Building Effective Biotech Alliances with Pharma in Japan
Glenn J. Gormley, Ph.D., President and Chief Executive Officer, Gemin X Pharmaceuticals

Launching the Alliance: What Big Pharma and Biotech Companies Need to Know
Bill Wilkison, Alliance Director, WorldWide Business Development, GlaxoSmithKline

A Case Study: The Albany Molecular Research, Inc.-Bristol-Myers Squibb Company Neuroscience Collaboration as a Successful Biotech - Pharmaceutical Alliance
Bruce J. Sargent, Ph.D., Vice President, Discovery R&D, Albany Molecular Research, Inc.
Timur Güngör, Ph.D., MBA, Associate Director, EST Alliance Management, Bristol-Myers Squibb Company

AstraZeneca and Argenta – “Combining Assets for Combination Therapy” – An Alliance Case Study
Caroline Austin, Ph.D.,  Business Development Director, Strategic Planning & Business Development, AstraZeneca
Harry Finch, Ph.D., Director, Argenta Discovery

How to Demonstrate The Value of the Alliance Management Function to your Organization and How to Get Senior Management Support – A Panel Discussion
Moderator: Susan Dorfman, Vice President, Global Marketing, CA-AM, Skila
Panelists:
Mike Leonetti, Chairman, ASAP, Executive Director, Healthcare Partnerships, Boehringer-Ingelheim Pharmaceuticals, Inc.
Ratnakar Mitra, Vice President, Global Licensing and Alliance Management, Schering Plough
Kimberly Brue, Alliance Director, Sanofi Pasteur
David Thompson, MBA, CA-AM, Director, Alliance Management, Office of Alliance Management, Eli Lilly and Company

Alliance Management and Decision Sciences - A Unique Problem Solving Combination
David Thompson, MBA, CA-AM, Director, Alliance Management, Office of Alliance Management, Eli Lilly and Company
James Felli, Director, Decision Sciences, Eli Lilly and Company

Structuring and Negotiating Alliance Deals for Success
Mike McCully, Director & Senior Analyst, Recombinant Capital 

“Getting it Right”: Genentech and UCSF’s Partnership in Asthma – Making Academic/Pharm Partnerships Work
Ashraf Hanna, Vice President, Alliance Management and Pipeline Strategy, Genentech
Teri Melese, Associate Professor, Department of Medicine, University of California, San Francisco, and Director of Research Technologies and Alliances, UCSF School of Medicine

KEY CONFERENCE FEATURES

KEY TOPICS – COME AND LEARN HOW TO:

Who Should Attend:
Biotech Firms

Big Pharma